iRegene
Wuhan
About iRegene
iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $27.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2025)
- Website: iregene.com
- Phone: 86 27 65522933
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/iregene-40546 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.